Literature DB >> 31494259

Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH) and normal controls.

Jiajie G Lu1, Askalu Iyasu1, Barbara French1, Brittany Tillman1, Samuel W French2.   

Abstract

Previously we have shown that in autoimmune hepatitis CD4 positive lymphocytes form an immunologic synapse with hepatocytes, leading to gradual diminishing and elimination of the hepatocyte. We wondered whether a similar mechanism may occur in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH). We conducted immunofluorescence studies of expression of MHCII, the binding partner of CD4, on patient liver biopsies of AH, NASH, and normal controls. In cases of alcoholic hepatitis, there was prominent sinusoidal expression of MHC II; In NASH biopsies there was comparatively lower expression of MHC II, but still more than control tissue. Immunohistochemical stain for CD4 showed CD4 positive lymphocytes closely associated with hepatocytes in AH biopsies. Furthermore, expression levels of the multifunctional cytokine IL-1α was higher in AH compared to NASH and control biopsies. These results underlie the more severe nature of alcoholic hepatitis and underscore the autoimmune mechanisms involved in the liver damage found in alcoholic hepatitis.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; CD4; Immune synapse; MHCII; Non-alcoholic steatohepatitis

Year:  2019        PMID: 31494259     DOI: 10.1016/j.alcohol.2019.08.008

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  2 in total

Review 1.  Functional heterogeneity of CD4+ T cells in liver inflammation.

Authors:  Franziska Muscate; Anna Woestemeier; Nicola Gagliani
Journal:  Semin Immunopathol       Date:  2021-08-31       Impact factor: 9.623

Review 2.  CD4+ T cell activation and inflammation in NASH-related fibrosis.

Authors:  Yunfeng Zhou; Haibo Zhang; Yao Yao; Xiaoyan Zhang; Youfei Guan; Feng Zheng
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.